These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32168444)

  • 1. [Analysis of determination of rabies virus neutralizing antibody titres in the sera of vaccinated humans.].
    Butirskiy AY; Muhacheva AV; Movsesyants AA; Sarkisyan KA
    Vopr Virusol; 2019; 64(6):298-305. PubMed ID: 32168444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans.
    Mansfield KL; Andrews N; Goharriz H; Goddard T; McElhinney LM; Brown KE; Fooks AR
    Vaccine; 2016 Nov; 34(48):5959-5967. PubMed ID: 27997343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between virus-neutralizing antibody levels and the number of rabies vaccinations: a prospective study of dogs in Japan.
    Watanabe I; Yamada K; Aso A; Suda O; Matsumoto T; Yahiro T; Ahmed K; Nishizono A
    Jpn J Infect Dis; 2013; 66(1):17-21. PubMed ID: 23429079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and efficacy of Fermi-type nerve tissue rabies vaccine in mice and in humans undergoing post-exposure prophylaxis for rabies in Ethiopia.
    Ayele W; Fekadu M; Zewdie B; Beyene M; Bogale Y; Mocha K; Egziabher FG
    Ethiop Med J; 2001 Oct; 39(4):313-21. PubMed ID: 12380231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study.
    Cantaert T; Borand L; Kergoat L; Leng C; Ung S; In S; Peng Y; Phoeun C; Hing C; Taing CN; Saman M; Ong S; Mey C; Choeung R; Ly S; Dussart P; Bourhy H; Tarantola A
    Lancet Infect Dis; 2019 Dec; 19(12):1355-1362. PubMed ID: 31570311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabies virus glycoprotein serology ELISA for measurement of neutralizing antibodies in sera of vaccinated human subjects.
    Zhao R; Yu P; Shan Y; Thirumeni N; Li M; Lv Y; Li J; Ren W; Huang L; Wei J; Sun Y; Zhu W; Sun L
    Vaccine; 2019 Sep; 37(41):6060-6067. PubMed ID: 31471146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artesunate enhances the immune response of rabies vaccine as an adjuvant.
    Luo J; Zhang Y; He H; Liu Q; Huang S; Guo X
    Vaccine; 2019 Dec; 37(51):7478-7481. PubMed ID: 31582270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.
    Kerdpanich P; Chanthavanich P; De Los Reyes MR; Lim J; Yu D; Ama MC; Mojares Z; Casula D; Arora AK; Pellegrini M
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006340. PubMed ID: 29874228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
    Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
    Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV).
    Fayaz A; Simani S; Janani A; Farahtaj F; Biglari P; Howeizi N; Eslami N
    Vaccine; 2011 May; 29(21):3742-5. PubMed ID: 21458608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroconversion following incomplete human rabies postexposure prophylaxis.
    Robertson K; Recuenco S; Niezgoda M; Garcia EJ; Rupprecht CE
    Vaccine; 2010 Sep; 28(39):6523-6. PubMed ID: 20637309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sero-prevalence of virus neutralizing antibodies for rabies in different groups of dogs following vaccination.
    Pimburage RMS; Gunatilake M; Wimalaratne O; Balasuriya A; Perera KADN
    BMC Vet Res; 2017 May; 13(1):133. PubMed ID: 28521804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of purified chick embryo cell anti-rabies vaccine in post-exposure treatment of animal bite cases.
    Bhardwaj M; Bhattacharya D; Chhabra M; Ichhpujani RL
    J Commun Dis; 2002 Mar; 34(1):40-2. PubMed ID: 12718340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, blind, controlled phase III clinical trial: Assessing the immunogenicity and safety of freeze-dried human rabies vaccine (vero cell) with a 4-dose regimen (2-1-1) in a 10-60 year-old demographic.
    Jin F; Zhu L; Wang Y; Qin G; Tian Y; Xie Y; Jin H; Zhang Y; Wang L; Li J; Wu Z; Sheng Y; Shi L; Yang G; Zhao Z; Chen L; Chen P; Jiang Z; Yu J; Gao Z; Li Q; Wu X; Miao L
    Vaccine; 2024 Oct; 42(23):126059. PubMed ID: 38937182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial.
    Alberer M; Gnad-Vogt U; Hong HS; Mehr KT; Backert L; Finak G; Gottardo R; Bica MA; Garofano A; Koch SD; Fotin-Mleczek M; Hoerr I; Clemens R; von Sonnenburg F
    Lancet; 2017 Sep; 390(10101):1511-1520. PubMed ID: 28754494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The induction of protective immune response in mice vaccinated by recombinant avian adenovirus CELO expressing glycoprotein G of the rabies virus].
    Shmarov MM; Tutykhina IL; Logunov DIu; Verkhovskai LV; Nedosekov VV; Tsybanov SZh; Novikov BV; Narodnitskiĭ BS; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (4):69-71. PubMed ID: 16941876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic Response of 2 Versus 3 Doses and Intradermal Versus Intramuscular Administration of a Licensed Rabies Vaccine for Preexposure Prophylaxis.
    Endy TP; Keiser PB; Wang D; Jarman RG; Cibula D; Fang H; Ware L; Abbott M; Thomas SJ; Polhemus ME
    J Infect Dis; 2020 Apr; 221(9):1494-1498. PubMed ID: 31802120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.